# Octapharma Plasma, Inc. Portsmouth – FDA Inspection, Sep 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc-portsmouth/1706f69c-2306-4cb3-a0dc-55f575d46a92
Source feed: FDA_Inspections

> FDA inspection 1066750 of Octapharma Plasma, Inc. Portsmouth, September 26, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1066750
- Company Name: Octapharma Plasma, Inc. Portsmouth
- Inspection Date: 2018-09-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1137609 - 2021-03-30
- [FDA Inspection 992370 - 2016-10-28](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc-portsmouth/15f7155b-22f1-4b9c-892d-3aa42f2ea425)
- FDA Inspection 838033 - 2013-06-20
- [FDA Inspection 733852 - 2011-06-28](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc-portsmouth/ffecfff3-542f-4658-858f-176088ee823f)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/kenneth-l-smalls/7625258c-cada-4506-8daa-a64374cf9f15)
- [Issuing Officer](https://www.keypedia.com/people/richard-j-bashay/ce50702d-1f5b-42c5-b50a-88bb43cba196)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc-portsmouth/2fa6f5e5-7eee-455b-98b7-2fc161cc917b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d